Imunon, Inc. — Director's Dealing 2024

Oct 8, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Imunon, Inc. (IMNN)
CIK: 0000749647
Period of Report: 2024-10-07

Reporting Person: Eylward Susan (General Counsel and Corp Sec)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-10-07	Stock Option (Right to Buy)	$1.02	A	50000	Acquired	2034-10-07	Common Stock (50000)	Direct

Footnotes

F1: Represents the closing price of Imunon, Inc. Common Stock on the date of the grant

F2: The options vest as follows 1/4 on the one year anniversary of the grant and 1/4 on the second, third and fourth year anniversary.